advertisement
11.16 Vehicles, delivery systems, pharmacokinetics, formulation (10)
Showing records 1 to 10
Search within classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation17155 Brimonidine in the treatment of glaucoma and ocular hypertension
Cantor LB
Therapeutics and Clinical Risk Management 2006; 2: 337-346
17051 Comparison of the stability, efficacy, and adverse effect profile of the innovator 0.005% latanoprost ophthalmic solution and a novel cyclodextrin-containing formulation
Gonzalez JR; Baiza-Duran L; Quintana-Hau J; Tornero-Montano R; Castaneda-Hernandez G; Ortiz M; Alarcon-Oceguera F; Beltran-Loustaunau M; Cortez-Gastelum M; Garciduenas-Mejia J
Journal of Clinical Pharmacology 2007; 47: 121-126
17092 Preparation and testing of buffered eye drops containing pilocarpine chloride with timolol maleate
Rakic D; Antunovic M
Vojnosanitetski pregled. Military-medical and pharmaceutical review 2006; 63: 873-877
17081 Efficiency of instillation methods for prostaglandin medications
Fiscella R; Wilensky JT; Chiang TH; Walt JG
Journal of Ocular Pharmacology and Therapeutics 2006; 22: 477-482
17176 Effect of switching from aqueous timolol to gel-forming timolol ophthalmic solution
Inoue K; Sogabe M; Wakakura M; Inouye J; Tomita G
Japanese Journal of Clinical Ophthalmology 2006; 60: 1971-1976
16897 Travoprost 0.004% with and without benzalkonium chloride: a comparison of safety and efficacy
Lewis RA; Katz GJ; Weiss MJ; Landry TA; Dickerson JE; James JE; Hua SY; Sullivan EK; Montgomery DB; Wells DT
Journal of Glaucoma 2007; 16: 98-103
17037 Second Ophthalmic Drug Development and Delivery Summit San Diego, CA, USA, 19-20 September 2006
Marra M; Gukasyan HJ; Raghava S; Kompella UB
Expert Opinion on Drug Delivery 2007; 4: 77-85
17154 Assessment of corneal epithelial integrity after acute exposure to ocular hypotensive agents preserved with and without benzalkonium chloride
Whitson JT; Cavanagh HD; Lakshman N; Petroll WM
Advances in Therapy 2006; 23: 663-671
16763 The effect of drop vehicle on the efficacy and side effects of topical glaucoma therapy: a review
Yee RW
Current Opinions in Ophthalmology 2007; 18: 134-139
17134 Patients' and physicians' perceptions of the travoprost dosing aid: An open-label, multicenter study of adherence with prostaglandin analogue therapy for open-angle glaucoma or ocular hypertension
Flowers B; Wand M; Piltz-Seymour J; Berke SJ; Day D; Teague J; Smoot TM; Landry TA; Bergamini MVW; Mallick S
Clinical Therapeutics 2006; 28: 1803-1811
